 SAN DIEGO, May 3, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced its support of Mental Health Month and commitment to raising awareness of and supporting people living with tardive dyskinesia TD. Some people living with a mental health condition may also experience TD, an involuntary movement disorder that may develop after a few months of taking certain medications to treat bipolar disorder, depression and schizophrenia.1-3 The uncontrollable movements of TD, which can affect the face, torso andor other body parts, may be disruptive to peoples lives due to the symptoms and impact on their physical, emotional and social well-being.1,2,4 To help raise awareness of TD, the mental health advocacy community and states across the country are recognizing the first full week of May 2-8 as Tardive Dyskinesia Awareness Week for the fourth year in a row. 